Back to Search Start Over

Overlapping genetic architecture between Parkinson disease and melanoma.

Authors :
Dube, Umber
Ibanez, Laura
Budde, John P.
Benitez, Bruno A.
Davis, Albert A.
Harari, Oscar
Iles, Mark M.
Law, Matthew H.
Brown, Kevin M.
23andMe Research Team
Agee, Michelle
Alipanahi, Babak
Auton, Adam
Bell, Robert K.
Bryc, Katarzyna
Elson, Sarah L.
Fontanillas, Pierre
Furlotte, Nicholas A.
Hinds, David A.
Huber, Karen E.
Source :
Acta Neuropathologica; Feb2020, Vol. 139 Issue 2, p347-364, 18p
Publication Year :
2020

Abstract

Epidemiologic studies have reported inconsistent results regarding an association between Parkinson disease (PD) and cutaneous melanoma (melanoma). Identifying shared genetic architecture between these diseases can support epidemiologic findings and identify common risk genes and biological pathways. Here, we apply polygenic, linkage disequilibrium-informed methods to the largest available case–control, genome-wide association study summary statistic data for melanoma and PD. We identify positive and significant genetic correlation (correlation: 0.17, 95% CI 0.10–0.24; P = 4.09 × 10<superscript>−06</superscript>) between melanoma and PD. We further demonstrate melanoma and PD-inferred gene expression to overlap across tissues (correlation: 0.14, 95% CI 0.06 to 0.22; P = 7.87 × 10<superscript>−04</superscript>) and highlight seven genes including PIEZO1, TRAPPC2L, and SOX6 as potential mediators of the genetic correlation between melanoma and PD. These findings demonstrate specific, shared genetic architecture between PD and melanoma that manifests at the level of gene expression. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00016322
Volume :
139
Issue :
2
Database :
Complementary Index
Journal :
Acta Neuropathologica
Publication Type :
Academic Journal
Accession number :
141453608
Full Text :
https://doi.org/10.1007/s00401-019-02110-z